rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ALVO
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Alvotech at UBS biopharma conference: pipeline, launches and scale
      Nov 17Investing.comALVOALVOWUBS
      Alvotech Stock After Earnings Loss What Changed
      Nov 15Yahoo FinanceALVOALVOW
      What Alvotech (ALVO) Said on Its Q3 Earnings Call
      Nov 12Yahoo FinanceALVOALVOW
      Alvotech Q3 2026 slides: manufacturing gains offset revenue miss
      Nov 12Investing.comALVOALVOW
      Earnings call transcript: Alvotech Q3 2026 revenue miss weighs on shares
      Nov 12Investing.comALVOALVOW
      Corteva Posts Downbeat Q3 Results, Joins Nvidia, Alvotech And Other Big Stocks Moving Lower In Thursday’s
      Nov 12BenzingaALVOALVOWCTVA
      Alvotech earnings missed by $0.03, revenue fell short of estimates
      Nov 12Investing.comALVOALVOW
      Alvotech (ALVO) Reports Q3 Loss, Lags Revenue Estimates
      Nov 11Yahoo FinanceALVOALVOW
      Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
      Nov 11Yahoo FinanceALVOALVOW
      Alvotech earnings on deck as biosimilar FDA decisions loom
      Nov 11Investing.comALVOALVOW
      Jefferies initiates Alvotech stock coverage with buy rating on biosimilar pipeline
      Nov 10Investing.comALVOALVOW
      Is Alvotech (NASDAQ:ALVO) Trading At A Discount To Its Sales?

      Alvotech has had a tough long term ride, and the current share price asks investors to judge whether the revenue behind the story is enough to support it. With so much of the recent experience tied to how sales can scale, the key issue is how the market price lines up with what the business actually sells today. Over the past 5 years the stock has fallen 50.9%, which puts the focus firmly on whether the current valuation still lines up with the company’s sales base. For a business built...

      Nov 8Yahoo FinanceALVOALVOW
      Alvotech (ALVO) Dropped, What Is Driving Attention Now?
      Nov 8Yahoo FinanceALVOALVOW
      Will Alvotech (ALVO) Report Negative Earnings Next Week? What You Should Know
      Nov 4Yahoo FinanceALVOALVOW
      Alvotech Stock: The Market Is Still Pricing The Broken Factory (NASDAQ:ALVO)
      Nov 3Seeking AlphaALVOALVOW
      Alvotech to Present at Upcoming Investor Conferences in November

      REYKJAVIK, ICELAND (November 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that members of the management team will participate in upcoming investor conferences in November as follows: UBS Global Biopharma Conference in London– fireside chat Tuesday, November 17 at 14:00 GMT (9:00 am ET).2026 Jefferies Global Healthcare Conference in London – presentation

      Nov 2Yahoo FinanceALVOALVOW
      Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

      REYKJAVIK, Iceland, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its financial results for the nine months and third quarter ended September 30, 2026 on Wednesday, November 11, 2026, after the U.S. market close. The Company will also host a webcast with a live Q&A on Thursday, November 12, 2026,

      Oct 28Yahoo FinanceALVOALVOW
      Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Alvotech (ALVO)

      Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.

      Oct 21The Globe and MailALVOALVOWGH
      Alvotech Wins FDA Nod for High-Yield SIMLANDI Manufacturing Upgrade

      Detailed price information for Alvotech (ALVO-Q) from The Globe and Mail including charting and trades.

      Oct 21The Globe and MailALVOALVOW
      Alvotech's Manufacturing Progress, Simponi Launch Potential Support Recovery, UBS Says
      Oct 20Yahoo FinanceALVOALVOWUBS
      Alvotech wins FDA for Humira biosimilar process (ALVO:NASDAQ)

      Alvotech (ALVO) stock gains as the FDA OKs new manufacturing process for Simlandi, the company's Humira biosimilar marketed with Teva (TEVA). Read more here.

      Oct 20Seeking AlphaALVOALVOW
      Alvotech Says FDA Approves New Manufacturing Process for Simlandi; Shares Rise Pre-Bell
      Oct 20Yahoo FinanceALVOALVOW
      Alvotech shares jump premarket after FDA approves new Simlandi process

      Investing.com -- Alvotech shares rose more than 6% in premarket trading Tuesday after the U.S. Food and Drug Administration approved a new manufacturing process for Simlandi, the company’s biosimilar to Humira.

      Oct 20Yahoo FinanceALVOALVOW
      Why is Alvotech stock climbing today?
      Oct 20Investing.comALVOALVOW
      FDA approves new manufacturing process for Alvotech biosimilar
      Oct 20Investing.comALVOALVOW
      Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch

      Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech’s biosimilars portfolio REYKJAVIK, Iceland and LONDON, UK (October 20, 2026) - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announcedthat the U.S. Food and Drug Administration (FDA) has approved a new manufacturing process for SIMLANDI® (adalimumab-ryvk), Alv

      Oct 20Yahoo FinanceALVOALVOW
      Alvotech Stock In Focus After Europe Filing For Eylea 8 Mg Copycat
      Oct 16Yahoo FinanceALVOALVOW
      Alvotech, Advanz seek EU nod for high-dose Eylea biosimilar
      Oct 14Yahoo FinanceALVOALVOW
      Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg

      AVT29 submitted to the European Medicines Agency as a line extension to the existing marketing authorization for Mynzepli® (aflibercept 2 mg) High-dose aflibercept offers the potential to reduce treatment frequency for patients with retinal diseases REYKJAVIK, Iceland and LONDON, UK (October 14, 2026) - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma Holdco Limited

      Oct 14Yahoo FinanceALVOALVOW
      Analysts Are Bullish on Top Healthcare Stocks: Alvotech (ALVO), Relay Therapeutics (RLAY)

      Detailed price information for Relay Therapeutics Inc (RLAY-Q) from The Globe and Mail including charting and trades.

      Oct 13The Globe and MailALVOALVOWRLAY
      Alvotech Strikes Long-Term U.S. Manufacturing Pact With LOTTE Biologics to Boost Biosimilar Supply

      Detailed price information for Alvotech (ALVO-Q) from The Globe and Mail including charting and trades.

      Oct 8The Globe and MailALVOALVOW
      LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply
      Oct 8Yahoo FinanceALVOALVOW
      Alvotech (ALVO) Could Be 14% Undervalued On Manufacturing Capacity Updates
      Oct 8Yahoo FinanceALVOALVOW
      Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply

      Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics’ Syracuse facility in New York Strategic long-term partnership to increase Alvotech’s global manufacturing capacity and support growth in demand REYKJAVIK, Iceland, and SEOUL, South Korea (October 6, 2026) - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and LOTTE Biologics, a contract developmen

      Oct 6Yahoo FinanceALVOALVOW
      Alvotech Wins FDA Nod to Double U.S. Manufacturing Capacity for Humira Biosimilar SIMLANDI

      Detailed price information for Alvotech (ALVO-Q) from The Globe and Mail including charting and trades.

      Oct 6The Globe and MailALVOALVOW
      Alvotech Soars 13% on FDA Nod That “Effectively Doubles” US Humira Biosimilar Capacity
      Oct 5Yahoo FinanceALVOALVOW
      Alvotech stock surges after FDA manufacturing approval

      Investing.com -- Alvotech SA (NASDAQ:ALVO) shares jumped 13.5% Monday after the U.S. Food and Drug Administration approved a supplement to the Biologics License Application for AVT02, enabling the company to manufacture the drug substance in a second production suite at its Reykjavik facility.

      Oct 5Yahoo FinanceALVOALVOW
      Why is Alvotech stock surging today?
      Oct 5Investing.comALVOALVOW
      FDA approves additional U.S. manufacturing capacity for Simlandi, Alvotech’s biosimilar to Humira

      FDA approves SIMLANDI (ALVO) manufacturing expansion at Alvotech’s Reykjavik plant, confirming resolved inspections and boosting supply.

      Oct 5Seeking AlphaALVOALVOW
      Alvotech Gets US FDA Approval For Additional Manufacturing Capacity For Simlandi Biosimilar; Shares Up Pre-Bell

      Alvotech (ALVO) has received US Food and Drug Administration approval for a supplement to the biolog

      Oct 5Yahoo FinanceALVOALVOW
      FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
      Oct 5Yahoo FinanceALVO
      Positive Report for Alvotech (ALVO) from Barclays

      Detailed price information for Alvotech (ALVO-Q) from The Globe and Mail including charting and trades.

      Sep 17The Globe and MailALVOALVOW
      Why This Biotech Stock Just Got a Rare Double Upgrade
      Sep 16Barron'sALVOALVOW
      Alvotech Shares Rise After Double Upgrade From Barclays

      Alvotech (ALVO) shares were up 7% in afternoon trading on Wednesday after Barclays upgraded the comp

      Sep 16Yahoo FinanceALVOALVOW
      Alvotech stock surges on Barclays upgrade to Overweight
      Sep 16Investing.comALVOALVOWBCS
      Alvotech stock gains on double upgrade at Barclays (ALVO:NASDAQ)
      Sep 16Seeking AlphaALVOALVOWBCS
      LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
      Sep 16BenzingaALVOALVOWTWST
      Alvotech Shares Rise 5.6% After Barclays Upgrades Rating and Doubles Price Target

      Alvotech (NASDAQ:ALVO) shares gained 5. 6% in premarket trading after Barclays upgraded the biosimilar drug developer from Underweight to Overweight and raised its price target from $4.

      Sep 16Yahoo FinanceALVOALVOWBCS
      Why is Alvotech stock rallying 5% today?
      Sep 16Investing.comALVOALVOW
      Barclays Upgrades Alvotech to Overweight From Underweight, Adjusts PT to $8 From $4
      Sep 16Yahoo FinanceALVOALVOW

      This is the newest page. Registered accounts read further back.